|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-3-18
|
|
pubmed:abstractText |
We studied whether different initial bacterial densities of Helicobacter pylori would alter the eradication rate of H. pylori by triple therapy (amoxicillin 500 mg t.i.d. and metronidazole 500 mg t.i.d. for 14 days; bismuth subcitrate 120 mg t.i.d. for 28 days) in patients with duodenal ulcer bleeding.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0016-5107
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
683-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8979058-Adult,
pubmed-meshheading:8979058-Amoxicillin,
pubmed-meshheading:8979058-Anti-Ulcer Agents,
pubmed-meshheading:8979058-Biopsy,
pubmed-meshheading:8979058-Drug Therapy, Combination,
pubmed-meshheading:8979058-Duodenal Ulcer,
pubmed-meshheading:8979058-Female,
pubmed-meshheading:8979058-Gastric Mucosa,
pubmed-meshheading:8979058-Helicobacter Infections,
pubmed-meshheading:8979058-Helicobacter pylori,
pubmed-meshheading:8979058-Humans,
pubmed-meshheading:8979058-Male,
pubmed-meshheading:8979058-Metronidazole,
pubmed-meshheading:8979058-Organometallic Compounds,
pubmed-meshheading:8979058-Penicillins,
pubmed-meshheading:8979058-Peptic Ulcer Hemorrhage,
pubmed-meshheading:8979058-Predictive Value of Tests,
pubmed-meshheading:8979058-Ranitidine,
pubmed-meshheading:8979058-Treatment Failure
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer.
|
|
pubmed:affiliation |
Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
